Heartflow Inc (HTFL)
Heartflow Inc. is a healthcare technology company listed on the NASDAQ under the ticker HTFL. The company develops non-invasive tools for assessing and managing coronary artery disease in the United States and international markets. Its HeartFlow Platform uses AI and computational fluid dynamics to build a personalized 3D model of a patient’s heart from a coronary CT angiography scan, supporting analysis of coronary anatomy and function. The platform includes Heartflow RoadMap Analysis for visualizing coronary arteries, Heartflow FFRCT Analysis for evaluating blood flow, and Heartflow Plaque Analysis for assessing coronary plaque. These tools are designed to provide information on blood flow, stenosis, and plaque characteristics to help support clinical decision-making. Formerly known as Cardiovascular Simulation, Inc., the company adopted the HeartFlow name in 2009 and was incorporated in 2007. It is headquartered in Mountain View, California.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-HTFL
|
$18.89
|
-25.2% Downside
|
Overvalued
|
$37
|
46.6% Upside
|
Undervalued
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 6, 2026
|
-19.5x
|
7.6x
|
11.4x
|
2.118 B
|
1.949 B
|
1.2%
|
76.9%
|
17.8
|
—
|
68.7%
|
